VIVO Cannabis (Formerly known as ABcann)
(TSXV: VIVO) (OTCQX: VVCIF) - Investor Dashboard

➔ VIVO Cannabis
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees:  41
Established: 2012
CEO: Barry Fishman

VIVO Cannabis – Management Team

Barry Fishman – Chief Executive Officer

Mr. Fishman has almost 20 years of experience as a business leader, most recently as CEO of international specialty pharmaceutical company Merus Labs (TSX:MSL) (NASDAQ:MSLI). Under his leadership, sales and EBITDA grew at a compound annual growth rate above 50%, culminating in the acquisition of Merus by Norgine B.V. in July, 2017 for approximately $342 million. He also has several years of experience serving as a director of public companies in the cannabis sector. Mr. Fishman previously served as CEO of both Teva Canada and Taro Canada, and is a past Chair of the Canadian Generic Manufacturers Association. He began his pharmaceutical career at Eli Lilly, where he advanced through several cross-functional leadership roles, including Vice President of Marketing.

Dr. Michael Bumby – CFO

Dr. Bumby has 20 years of experience in the pharmaceutical industry. Over the course of his career, he has served as CFO of three publicly held Canadian companies, most recently Merus Labs. Dr. Bumby completed a doctorate degree in Veterinary Medicine at the University of Guelph and an MBA from the University of Toronto.

Sung Kang – Chief Marketing Officer

Mr. Kang has more than 15 years of marketing experience. He has held leadership roles at companies like General Mills and Novartis Consumer.

Joel Mallard – Chief Customer Officer

Mr. Mallard has 20 years of experience in sales and marketing. Previously, he has held leadership positions with beverage company Diageo and Cowbell Brewing Co.

Shekhar Parmar – CEO of Harvest Medicine and Chief Strategy Officer

Mr. Parmar has more than 10 years of experience as a lawyer and entrepreneur. As CEO of Harvest Medicine, he led the company to become one of the fastest growing group of cannabis clinics.

Andrew LaCroix – VP, International and General Counsel

Andrew LaCroix started his legal career working for blue chip firms in Vancouver, and has run his own practice on Vancouver Island since 2008. Andrew has been involved with the company since its inception as general counsel, drafting and submitting VIVO Cannabis’s initial Health Canada license application and acting as general counsel on a host of different business and legal issues. Andrew will provide the company with ongoing advice, and play a large role in both domestic and international business development.

Jenny Guan – Vice President and General Manager

Ms. Guan has more than 15 years of business operations and financial leadership experience. She is an initial team member of the company.

Ray Laflamme – SVP, Facilities and Engineering

Mr. Laflamme brings 45 years of experience in engineering, design, construction, and project management to the company. He has commissioned a number of large industrial, food-grade facilities in North America, including the Canna Farms’ facility.

Daniel Laflamme – President, Canna Farms

Mr. Laflamme has more than 15 years of experience in the finance, operations, and regulatory spaces. Before founding Canna Farms, he was the Managing Director for Amberwood Homes.

Aaron Keay – Director

Aaron has spent the last 11 years working in the capital markets across a broad spectrum of sectors. Aaron’s roles have ranged from corporate finance, senior management and board member. He has overseen finance and M&A transactions and Capital raising, helping private companies navigate from the private to public markets. His work and leadership has helped raise ~$250m for public and private market issuers.

Daryl Kramp – Director

daryl-kramp-abcannWas the Member of Parliament for the riding of Prince Edward-Hastings from 2004 through October of 2015. His past political experience includes six years as a municipal councilor and deputy reeve in the municipality of Madoc. Mr. Kramp brought vast experience in the private sector to his role. He has created and operated several successful business ventures in the fields of retail, wholesale and hospitality.

John Easson – Director

john-easson-abcannJohn has over 23 years of experience advising companies on Corporate Finance, and Mergers and Acquisition transactions. Whether it be through his own BE Capital Advisors practice or his 15 years working for BMO, RBC and Scotiabank, John has significant transaction experience with a range of companies from small private start-ups to some of Canada’s largest public companies.

Richard Fitzgerald – Director

Mr. Fitzgerald has years of experience in the alcohol and tobacco industries. He is the former CEO and Chairman of Diageo Canada.

Paul Lucas – Chairman

paul-lucas-abcannMr. Lucas served as President and CEO of GlaxoSmithKline Canada from 1994 until he retired in 2012. Currently Mr. Lucas is a member of the Board of Directors of RnA Diagnostics Inc and He is also Chair of the Board of EcoSynthetix Inc., Induran Ventures Inc., and Life Sciences Ontario. He received his BSc (Honours) in Biology and Chemistry from Queen’s University, and obtained his Chartered Directors designation (CDir) from the Directors College.

Significant Insider Ownership

Barry Fishman, CEO
1.125mm shares and 1.25mm options

Jenny Guan, VP and General Manager
11.07mm shares

Andrew LaCroix,  VP International and General Counsel 
1.23mm shares

Aaron Keay, Director
1.1mm shares

Paul Lucas, Chairman

Visit VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.)

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.) is a client of NCV Media, LLC. Read our full disclaimer.